Zarkin GA, Dunlap LJ, Hicks KA, Mamo D. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ. 2005 Nov 1;14(11):1133-50.
Hill CD, Fehnel SE, Hogue SL. Patient-perceived differences among commonly used antidepressants: a web-based survey. Poster presented at the US Psychiatric & Mental Health Congress; November 1, 2005.
Williams V, Morlock R, Fehnel S, Wills MM, Hill CD, Barrows S, Cappelleri J, Feltner D. Development and evaluation of the daily assessment of symptoms–anxiety (DAS-A) scale for measurement of onset of symptom relief in patients with gad. Poster presented at the 12th Annual Conference of the International Society for Quality of Life Research; October 19, 2005. San Francisco, CA.
McLeod LD, Fehnel SE, Willis MM, Hamm LR, Gilchrist KA. Psychometric validation of a patient-reported instrument assessing functional status in bipolar disorder. Poster presented at the 12th Annual Conference of the International Society for Quality of Life Research; October 19, 2005. San Francisco, CA.
Burdett AN, Gard C, Gilsenan A, Hirji Z, Raskin J, Miller D. Prevalence and costs associated with treating depression with painful physical symptoms in a Canadian administrative services database. Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2005. Nashville, TN.
Garcia-Esteve L, Torres A, Navarro P, Aguado J, Ascaso C. Maternidad the planned y psicomorbilidad: un riesgo evitable / Unplanned pregnancy and psychological morbidity: an avoidable risk. Fac Med Barc. 2005 Jul;32(3):111-8.
McKenna SP, Meads DM, Doward LC, Tennant A. Improving the scaling properties of the Psychological General Well-Being Scale (PGWB). Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):380.
Doward LC, Tai SJ, Taylor JL. An exploratory study to develop a model of quality of life for bipolar disorder. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):390.
Morlock R, Williams VS, Feltner D, Cappelleri JC, Endicott J. Evaluation of the daily assessment of symptoms – anxiety (DAS-A) questionnaire in a clinical trial comparing lorazepam and paroxetine in patients with generalized anxiety disorder. Poster presented at the Annual Meeting of the American Psychiatric Association; May 2005.
Morlock R, Williams VS, Feltner D, Cappelleri JC, Brock J, Endicott J. Evaluation of the daily assessment of symptoms – anxiety (DAS-A) questionnaire in patients with generalized anxiety disorder. Poster presented at the Annual Conference of the Anxiety Disorders Association of America; March 2005.
DiBenedetti DB, Russell J, Davidson J, Katzman M, Marciniak M, Yurgin N. Measuring the burden of generalized anxiety disorder in North America. Poster presented at the 25th Anxiety Disorders Association of America Annual Conference; March 2005.
DiBenedetti DB, Russell J, Jacobi F, Yurgin N, Davidson J, Katzman M. Measuring the global burden of generalized anxiety disorder (GAD). Poster presented at the 25th Anxiety Disorders Association of America Annual Conference; March 2005.
Bray JW, Davis KL, Graver L, Schroeder D, Buck JA, Dilonardo J, Vandivort R. Mental health and substance abuse treatment utilization among individuals served by multiple public agencies in 3 states. J Behav Health Serv Res. 2005 Jan 1;32(3):282-93.